Relay Therapeutics (RLAY)
(Delayed Data from NSDQ)
$6.58 USD
+0.17 (2.65%)
Updated Oct 10, 2024 04:00 PM ET
After-Market: $6.58 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.77 | 2.08% |
Earnings Summary
For their last quarter, Relay Therapeutics (RLAY) reported earnings of -$0.69 per share, beating the Zacks Consensus Estimate of $-0.73 per share. This reflects a positive earnings surprise of 5.48%. Look out for RLAY's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.77 per share, reflecting a year-over-year decrease of 42.59%.
Earnings History
Price & Consensus
Zacks News for RLAY
Biotech Stock Roundup: TERN, SMMT Stocks Surge on Study Data, GSK's Vaccine Study Fails & More
RLAY: What are Zacks experts saying now?
Zacks Private Portfolio Services